A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study

Lam, Marnix; Garin, Etienne; Maccauro, Marco; Kappadath, S.; Sze, Daniel; Turkmen, Cüneyt; Cantasdemir, Murat; Haste, Paul; Herrmann, Ken; Alsuhaibani, Hamad; Dreher, Matthew; Fowers, Kirk; Salem, Riad

doi:10.1007/s00259-022-05774-0

A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study

Lam M., Garin E., Maccauro M., Kappadath S. C., Sze D. Y., Turkmen C., ...Daha Fazla

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.49, sa.10, ss.3340-3352, 2022 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 49 Sayı: 10
Basım Tarihi: 2022
Doi Numarası: 10.1007/s00259-022-05774-0
Dergi Adı: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Biotechnology Research Abstracts, CINAHL, EMBASE, MEDLINE
Sayfa Sayıları: ss.3340-3352
Anahtar Kelimeler: Radioembolization, Yttrium-90, Dosimetry, Hepatocellular carcinoma, MULTICENTER, SURVIVAL
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
İstanbul Üniversitesi Adresli: Evet

Özet

Purpose To investigate the relationships between tumor absorbed dose (TAD) or normal tissue absorbed dose (NTAD) and clinical outcomes in hepatocellular carcinoma (HCC) treated with yttrium-90 glass microspheres.